165 related articles for article (PubMed ID: 8888803)
1. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year follow-up. Tokai HCFU Study Group--third study on colorectal cancer.
Ito K; Yamaguchi A; Miura K; Kato T; Baba S; Matsumoto S; Ishii M; Takagi H
J Surg Oncol; 1996 Oct; 63(2):107-11. PubMed ID: 8888803
[TBL] [Abstract][Full Text] [Related]
2. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.
Nakamura T; Ohno M; Tabuchi Y; Kamigaki T; Fujii H; Yamagishi H; Kuroda Y;
Int J Oncol; 2001 Aug; 19(2):291-8. PubMed ID: 11445841
[TBL] [Abstract][Full Text] [Related]
3. Prospective adjuvant therapy with mitomycin C and carmofur (HCFU) for colorectal cancer, 10-year follow-up: Tokai HCFU Study Group, the first study for colorectal cancer.
Ito K; Yamaguchi A; Miura K; Kato T; Koike A; Takagi H
J Surg Oncol; 1996 May; 62(1):4-9. PubMed ID: 8618399
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
[TBL] [Abstract][Full Text] [Related]
6. Post-operative adjuvant chemotherapy for colorectal cancer with 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration after curative resection.
Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Toge T; Nakamura T; Nakasato H; Orita K
Anticancer Res; 2001; 21(6A):4163-8. PubMed ID: 11911312
[TBL] [Abstract][Full Text] [Related]
7. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
[TBL] [Abstract][Full Text] [Related]
8. Postoperative chemotherapy for colorectal cancer by combining 5-fluorouracil infusion and 1-hexylcarbamoyl-5-fluorouracil administration after curative resection.
Sugimachi K; Maehara Y; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Cancer; 1996 Jan; 77(1):36-43. PubMed ID: 8630937
[TBL] [Abstract][Full Text] [Related]
9. [Mitomycin C plus HCFU adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma. (Second report): 5-year survival rate. Cooperative Study Group of Kyushu and Chugoku for HCFU Adjuvant Chemotherapy].
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):333-9. PubMed ID: 2494948
[TBL] [Abstract][Full Text] [Related]
10. [Appropriate duration of postoperative oral adjuvant chemotherapy with HCFU for colorectal cancer].
Ito K; Okushiba S; Morikawa T; Kondo S; Katoh H
Gan To Kagaku Ryoho; 2004 Jan; 31(1):55-9. PubMed ID: 14750322
[TBL] [Abstract][Full Text] [Related]
11. [Multicenter comparative study of the recurrence-inhibitory effect of oral fluoropyrimidine drugs in patients with colorectal cancer following curative resection].
Sadahiro S; Mitomi T; Noto T; Kumada K; Hiki Y; Yamakawa T; Amano T; Oki S; Otani Y; Oka H; Takahashi T; Takemiya S; Nishiyama K; Yamamura T; Tsuchiya S; Ogawa N;
Gan To Kagaku Ryoho; 2005 Jul; 32(7):997-1005. PubMed ID: 16044962
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral adjuvant therapy with Carmofur (HCFU) for distant metastasis of colorectal cancer.
Ito K; Yamaguchi A; Miura K; Kato T; Baba S; Matsumoto S; Ishii M; Takagi H
Int J Clin Oncol; 2000 Feb; 5(1):29-35. PubMed ID: 20563694
[TBL] [Abstract][Full Text] [Related]
13. A multicenter randomized study comparing 5-fluorouracil continuous infusion (ci) plus 1-hexylcarbamoyl-5-fluorouracil and 5-FU ci alone in colorectal cancer.
Kotake K; Ohashi Y; Kodaira S; Koyama Y;
Oncol Rep; 2005 Jul; 14(1):129-34. PubMed ID: 15944779
[TBL] [Abstract][Full Text] [Related]
14. Mitomycin C plus carmofur (HCFU) adjuvant chemotherapy for noncuratively resected cases of colorectal carcinoma (interim report).
Niimoto M; Hattori T; Tamada R; Sugimachi K; Inokuchi K; Ogawa N
Jpn J Surg; 1987 Sep; 17(5):354-61. PubMed ID: 3123756
[TBL] [Abstract][Full Text] [Related]
15. [Neo-adjuvant chemotherapy with carmofur for colorectal cancer--a multi-institutional randomized controlled study].
Kotake K; Koyama Y; Shida S; Tajima Y; Ishikawa H; Kanazawa K; Miyata M; Nagamachi Y; Iwasaki Y; Omoto R; Tamakuma S; Kitajima M; Kodaira S;
Gan To Kagaku Ryoho; 2002 Nov; 29(11):1917-24. PubMed ID: 12465390
[TBL] [Abstract][Full Text] [Related]
16. Oral HCFU for prevention of hepatic metastasis in an experimental colorectal carcinoma.
Ito K; Wang L; Ye C; Ando H; Hibi K; Hidemura K; Akiyama S; Kasai Y; Nakao A
Anticancer Res; 2001; 21(2A):899-904. PubMed ID: 11396182
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil.
Watanabe M; Kodaira S; Takahashi T; Tominaga T; Hojo K; Kato T; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
Langenbecks Arch Surg; 2006 Aug; 391(4):330-7. PubMed ID: 16823593
[TBL] [Abstract][Full Text] [Related]
18. [A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer].
Misaki T; Hisazumi H; Sakai A; Nakamura T; Kanda S; Mikawa I; Miyagi T; Katsumi T; Orito M; Kawaguchi K
Hinyokika Kiyo; 1985 Jul; 31(7):1233-41. PubMed ID: 3933287
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of HCFU absorption after resection for gastric cancer--application of hydroxyaluminium gel].
Kageyama T; Toizumi A; Tamura Y
Gan To Kagaku Ryoho; 2001 Jun; 28(6):803-7. PubMed ID: 11432348
[TBL] [Abstract][Full Text] [Related]
20. [Prospective adjuvant chemotherapy, with mitomycin C plus long-term carmofur in colorectal cancer].
Terabe K; Yamauchi M; Watanabe T; Ichihashi H; Takagi H; Imaizumi M; Kondo T
Gan No Rinsho; 1986 Mar; 32(3):261-7. PubMed ID: 3086597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
